Moderna, Inc. is a company in the U.S. stock market and it is a holding in 186 U.S.-traded ETFs. MRNA has around 29.6M shares in the U.S. ETF market. The largest ETF holder of MRNA is the Invesco QQQ Trust (QQQ), with approximately 5.18M shares. Investors may also find of interest that the ETF with the largest allocation to MRNA stock is Invesco Nasdaq Biotechnology ETF (IBBQ), with a portfolio weight of 13.11%. On average, U.S. ETFs allocate 1.49% of MRNA to their portfolios.

Additionally, MRNA is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MRNA as a holding is the ProShares Ultra QQQ (QLD), with a return of 241.44%.